Follow Us

Global Acne Therapeutics Market Size, Segmentation, Trends and Growth Analysis Forecast by 2030

  •   DLR4943
  •   May, 2024
  •   Pages: 150
  •  Global

Acne Therapeutics Market Overview and Analysis:

The Acne Therapeutics Market size is currently valued at USD 8.24 billion in 2023, registering a CAGR of 4.89% during the forecast period (2023-2030).

Acne Therapeutics Market

Get Complete Analysis Of The Report - Download Free Sample PDF

Acne therapeutics refers to a range of medical treatments, medications, and therapies used to manage and alleviate the symptoms of acne, a common skin condition characterized by the development of pimples, blackheads, whiteheads, and other types of skin lesions. Acne is typically caused by the inflammation and blockage of hair follicles and sebaceous glands in the skin, often associated with excess oil production and the growth of bacteria on the skin. The key factors propelling the growth of the acne therapeutics market are increasing sedentary lifestyles, the rise in disposable income of consumers, rising awareness about upcoming trends in acne treatments, and the high prevalence of acne globally.

Acne Therapeutics Market Latest Trends:

Dermatologists are increasingly adopting personalized approaches to acne treatment. This involves tailoring therapies to an individual's specific skin type, the type and severity of acne, and other factors like lifestyle and hormonal imbalances. Personalized treatments can lead to better outcomes and reduced side effects. Research on the skin microbiome has led to the development of products designed to preserve and promote a healthy balance of skin bacteria. Maintaining a healthy microbiome is seen as a potential approach to prevent and treat acne.

Market Segmentation: The Acne Treatment Market is Segmented by Treatment (Therapeutics and Other Treatments), Route of Administration (Oral and Topical), and Geography (North America, Europe, Asia-pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD Million) for the Above Segments.

Acne Therapeutics Market Segmentation

For Detailed Market Segmentation - Download Free Sample PDF

Market Drivers :

Increasing Sedentary Lifestyle and Unhealthy Food Habits Leading to High Global Acne Prevalence

Prolonged sitting and excessive screen time are often associated with high-stress levels. Chronic stress triggers the release of hormones like cortisol, which can lead to increased sebum (skin oil) production and inflammation, both of which are central to the development of acne. Lack of physical activity can result in reduced blood circulation, impairing the delivery of oxygen and nutrients to the skin. Poor circulation may impede the skin's ability to repair itself and fight off acne-causing bacteria. Thus, owing to such advantages, the market is expected to witness significant growth over the forecast period. Moreover, according to data released by ClickPharmacy in May 2022, it was reported that 34% of adults in the United Kingdom have experienced acne at some point in their lives. The same source indicated that in 2022, 6.1% of men were currently dealing with acne, while 2.5% of women were facing the condition. In a separate study published in the Sahel Medical Journal in March 2021, it was mentioned that the prevalence of acne vulgaris in South Nigeria stood at 37.3%, with a higher occurrence among females at 37.6% compared to males at 36.7%. As a result, the increasing incidence of acne is expected to drive higher adoption of acne therapeutics, thereby fueling the growth of the market. Thus, such instances are expected to drive the growth of the studied market.

Increasing Awareness About Current and Upcoming Acne Treatments

Greater awareness has also emphasized the importance of early intervention in managing acne. Individuals are learning about the significance of addressing acne in its early stages to prevent the development of severe forms or scarring. This has led to a proactive approach to skincare and healthcare seeking behavior.

For instance, in March 2021, Galderma introduced a novel digital campaign known as "Me Being Me" to promote their topical acne treatment featuring Aklief (trifarotene) Cream. Throughout the year, the company dedicated significant efforts to educate patients about Aklief, marking it as the first newly approved retinoid molecule for the treatment of acne vulgaris in over two decades. Initiatives like this offer a glimpse into the future of acne treatment, and such campaigns are expected to contribute to the expansion of the market in the foreseeable future.

Market Restraints :

Safety Issues Regarding the Products and Entry of Generics in the Market

The global acne therapeutics market, while witnessing substantial growth, faces several challenges that have the potential to impede its expansion. Many acne treatments, especially topical products containing active ingredients like benzoyl peroxide, and salicylic acid, can cause skin irritation, dryness, and redness. This discomfort may deter individuals from continuing their treatment regimen. As a esult the growth of the market is expected to slow down over the forecast period.

COVID-19 Impact on Acne Therapeutics Market

The growth of the market was significantly affected by the COVID-19 pandemic. Stringent regulations imposed by government authorities resulted in a notable decline in patient visits to dermatology hospitals and clinics. An illustrative example can be found in a November 2021 NCBI study, accessible through the National Library of Medicine, which reported reduced patient volume in dermatology clinics, a decrease in aesthetic procedures, and a rise in the utilization of virtual healthcare services by board-certified dermatologists in North America. Thus, the relaxation of stringent lockdown regulations in the post-pandemic era is anticipated to lead to an upswing in patient traffic to dermatology clinics, consequently fueling market growth during the forecast period.

Segmental Analysis:

Retinoid Segment is Expected to Witness Growth Over the Forecast Period

Retinoids, a class of chemical compounds derived from vitamin A, have long been at the forefront of acne treatment. These topical or oral medications are highly regarded for their effectiveness in addressing various aspects of acne pathogenesis. Retinoids work by promoting the shedding of dead skin cells, preventing them from accumulating in hair follicles and clogging pores. By keeping the pores clear, retinoids reduce the formation of comedones (blackheads and whiteheads), one of the primary acne lesions. As a result, the segment is expected to witness significant growth over the forecast period.

Topical Segment is Expected to Witness Growth Over the Forecast Period

Topical therapies are often the initial choice for managing acne, particularly in mild to moderate cases. They are readily accessible, easy to use, and can be an effective starting point for many patients. Topical therapies are a cornerstone of acne treatment, offering a versatile and effective approach for managing this common skin condition. Their mechanisms of action, accessibility, and role in complementary therapy make them invaluable in the arsenal of acne therapeutics. Whether used alone or in combination with other treatments, topical therapies contribute to clearer, healthier skin, promoting improved self-esteem and overall well-being for individuals grappling with acne. As a result, the segment is expected to witness significant growth over the forecast period.

North America Region is Expected to Witness Significant growth Over the Forecast Period

North America is poised to capture a significant market share during the forecast period due to heightened public awareness and the presence of major industry players. The increasing prevalence of acne in the region and recent product introductions serve as pivotal drivers for the expansion of the acne therapeutics market in North America. According to data from MDAcne published in January 2021, a staggering 85% of individuals in the United States have encountered acne in some form at some point in their lives. The report also disclosed that approximately 50 million people in the United States grapple with various forms of acne. Similarly, a survey report from the Canadian Skin Patient Alliance (CSPA) in September 2022 revealed that 37% of respondents in Canada reported experiencing mild acne, 47% cited moderate acne, and 16% indicated severe acne. Additionally, a study published by NCBI in September 2021 further underscored the significant impact of acne in North America.

The rising number of product approvals in the realm of acne treatment is another catalyst expected to propel growth in this segment over the forecast period. For example, in August 2022, Cutera received clearance from Health Canada for AviClear, a product designed for the treatment of mild, moderate, and severe acne, as well as acne scars. Furthermore, major industry players in the region are actively developing innovative products and technologies to compete with existing offerings. Some are engaging in strategic acquisitions and partnerships with other emerging companies in the ever-evolving acne therapeutics market. For instance, in July 2022, Sun Pharmaceuticals and Cosmo Pharmaceuticals expanded their licensing and supply agreements for WINLEVI cream into the Mexican market. Thus, the region is expected to witness significant growth over the forecast period.

Acne Therapeutics Market

Get Complete Analysis Of The Report - Download Free Sample PDF

Acne Therapeutics Market Competitive Landscape:

The acne therapeutics market is highly competitive and consists of several major and local players. The market is expected to drive due to the rise in research on acne treatment and product approvals for acne treatment, among others. Some major players in this market include:

  • Abbvie Inc. (Allergan PLC)
  • Johnson & Johnson
  • L'Oréal S.A. (La Roche-Posay Laboratoire Dermatologique)
  • Teva Pharmaceutical
  • Sun Pharmaceutical Industries, Inc

Recent Developments

1. In March 2022, Galderma Launched TWYNEO Cream in the United States to treat facial acne at the American Academy of Dermatology Annual Meeting, which is commercially available in spring.

2. In January 2022, Journey Medical Corporation acquired two Food and Drug Administration-approved topical minocycline products and the molecule Stabilizing Technology (MST) Franchise from VYNE Therapeutics, Inc. This franchise includes AMZEEQ for the treatment of acne.

Frequently Asked Questions (FAQ) :

Q1. What is the current Acne Therapeutics Market size?

The Acne Therapeutics Market size is currently valued at USD 8.24 billion.

Q2. What is the Growth Rate of the Acne Therapeutics Market?

Acne Therapeutics Market is registering a CAGR of 4.89% during the forecast period.

Q3. Which Region is expected to hold the highest Market share?

North America region is expected to hold the highest Market share.

Q4. What segments are covered in the Acne Therapeutics Market Report?

By Treatement, By Route of Administration and Geography are the segments covered in the Acne Therapeutics Market Report.

Request for TOC

Request for List of Figure

Research Process

Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.

In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization



Primary Research

Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.

In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.

It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.

Secondary Research

Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.

Market Size Estimation

Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.

Forecast Model